Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07470723 · ClinicalTrials.gov registry record · NA
The ORIGIN-FH Study
A NA study of Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia (HeFH), sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07470723 is a NA study of Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia (HeFH) that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 70 participants, below the 216-participant average among 7 other Familial Hypercholesterolemia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07470723, a NA study of Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia (HeFH), is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected Participants can expect to be in the trial for 2 years.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Screening for FH
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-02-14 |
| Est. Completion | 2029-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07470723
The ClinicalTrials.gov registry entry for NCT07470723 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 216-participant average among 7 other Familial Hypercholesterolemia trials with a reported enrollment target (68% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Familial Hypercholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which Screening for FH is the first listed.
NCT07470723 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07470723 about?
NCT07470723 is a clinical study titled "The ORIGIN-FH Study". The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected Participants can expect to be in the trial for 2 years.
What is the current status of trial NCT07470723?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-02-14. Estimated completion is 2029-02-14.
What conditions does trial NCT07470723 study?
This clinical trial studies the following conditions: Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH).
What interventions are being tested in trial NCT07470723?
The interventions under investigation include: Screening for FH (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07470723?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07470723 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Atlantic Lipid Lowering Treatment Optimization Program
RECRUITING · NA
-
Comparing Direct vs Indirect Methods for Cascade Screening
RECRUITING · NA
-
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
RECRUITING · Phase 2
-
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
ACTIVE NOT RECRUITING · Phase 3
-
Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers
COMPLETED
-
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)
COMPLETED · Phase 3
Explore more on PlainTrial
Familial Hypercholesterolemia
All registered trials for this condition
Heterozygous Familial Hypercholesterolemia (HeFH)
All registered trials for this condition
Wisconsin
All trials with a study site in Wisconsin
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.